Takeda pays $800m for US gout drug maker URL Pharma
This article was originally published in Scrip
Takeda is to acquire the private US company URL Pharma, which makes gout drug Colcrys (colchicine), for $800 million. It will pay in cash, and has agreed to make additional payments based on future performance.
Register for our free email digests: